Chinese experts'consensus on the comorbidity management in perioperative period of transcatheter aortic valve replacement
The burden of valve disease in our country is heavy.In the past decade,transcatheter aortic valve replacement(TAVR)has been an important treatment method for aortic valve stenosis and has received a lot of research evidence to support it.The indications for TAVR are mostly elderly people,those with multiple diseases and medications,and those who are frail.The types,conditions and management of comorbidities during perioperative period of TAVR surgery,directly affect the prognosis of patients.In order to standardize the management of comorbidities during the perioperative period of TAVR,a collaborative group of Chinese experts has discussed and formulated a consensus on the diagnosis and treatment of comorbidities during the perioperative period of TAVR.They have unified opinions on the treatment of seven comorbidities,including frailty,coronary heart disease,neurological diseases,tumors,non cardiac surgical needs,end-stage kidney disease,and severe pulmonary dysfunction.